Mehmet M. Catlı
Antalya, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO).
Journal: JCO global oncology
Published: March 26, 2026
Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study (TOG/GI-SAFRADJU-2501).
Journal: International journal of cancer
Published: February 09, 2026
Critical Role of Model Selection in Evaluating AI Performance for Tumor Board Decision Making.
Journal: JCO clinical cancer informatics
Published: December 11, 2025
Prognostic Impact of Cetuximab-Related Hypomagnesemia and Hypokalemia in RAS/RAF Wild-Type Colorectal Cancer: A Multicenter Study.
Journal: Cancer management and research
Published: October 15, 2025
From Discussion to Direction: Tumor Boards Need Clinical Editorial Leadership.
Journal: JCO oncology practice
Published: September 19, 2025
Re: "Re-biopsy Feasibility and Clinical Impact on Metastatic Non-Small-Cell Lung Cancer with EGFR/ALK/ROS Oncogenic Driver Progression after Optimal Targeted Therapy: A Multicenter Real-World Analysis".
Journal: Clinical lung cancer
Published: August 25, 2025
Re: "Changing Lung Cancer Resection Outcomes Over Two Decades".
Journal: Clinical lung cancer
Published: August 20, 2025
Dose matters: a dose-stratified real-world analysis of magnesium sulfate in preventing cisplatin-induced nephrotoxicity.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: May 01, 2025
Colorectal cancer treatment commentary review.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 07, 2025
Letter Re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according To BRCA1/2 mutation type and site: a multicenter real-world study: Not all BRCA mutations are equal: functional context and mutation type as co-determinants of PARP inhibitor.
Journal: ESMO open
Published: April 04, 2025
Letter of comment: Reinforcing interpretation of avelumab maintenance in older adults: geriatric-sensitive perspectives from the JAVELIN Bladder 100 analysis.
Journal: ESMO open
Published: April 02, 2025
Last Updated: 09/26/2026